Physiological Measurements Confirming the Diagnosis of Cystic Fibrosis: The Sweat Test and Measurements of Transepithelial Potential Difference

Paediatric Respiratory Reviews

Volumn 10, Issue 4, 2009, Pages 220-226

  Taylor, C J ^a   Hardcastle, J ^a   Southern, K W ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cystic fibrosis; Diagnosis; Intestinal current measurement; Nasal potential difference; Sweat test

Indexed keywords

CELL MEMBRANE POTENTIAL; CYSTIC FIBROSIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SWEATING;

CYSTIC FIBROSIS; HUMANS; MEMBRANE POTENTIALS; SWEATING;

EID: 76549091391     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2009.05.002     Document Type: Review

References (78)

1. Di Sant' Agnese P.A., Darling R.C., Perera G.A., Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 1953, 12:549-563.
2. Gibson L.E., Cooke R.E. A test for the concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959, 23:545-549.
3. Rosenstein B.J., Cutting G.R. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998, 132:589-595.
4. Schwartz I.L., Thaysen J.H., Haysen, Dole V.P. Sodium and potassium excretion in human sweat. Am. J. Physiol 1954, 179:671.
5. Quinton P.M. Physiological Basis of Cystic Fibrosis: A Historical Perspective. Physiological Reviews 1999, 79(No. 1):S3-S22.
6. Quinton P.M., Reddy M.M. Regulation of absorption by phosphorylation of CFTR. Jpn J Physiol. 1994, 44(Suppl 2):S207-S213.
7. Tarran R., Button B., Boucher R.C. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol 2006, 68:543-561.
8. Reddy M.M., Quinton P.M. Functional interaction of CFTR and ENaC in sweat glands. Pflugers Arch 2003, 445:499-503. Epub 2002 Nov 21.
9. Gleeson M., Henry R.L. Sweat sodium or chloride?. Clin Chem 1991, 37:112.
10. Slegers J.F.G. The Secretion and Reabsorption of Salt and Water in the Sweat Gland: a Comparative Study Between Normal Subjects and Patients Suffering From Fibrocystic Disease. Pflügers Arch 1966, 290:231-236.
11. Augarten A., Hacham S., Kerem E., et al. The significance of sweat Cl/Na ratio in patients with borderline sweat test. Pediatr Pulmonol. 1995, 20:369-371.
12. di SAnt'Agnese P.A., Powell G.F. The eccrine sweat defect in cystic fibrosis of the pancreas. Ann NY Acad Sci 1962, 93:555-599.
13. Shamsuddin A.K., Yanagimoto S., Kuwahara T., Zhang Y., Nomura C., Kondo N. Changes in the index of sweat ion concentration with increasing sweat during passive heat stress in humans. Eur J Appl Physiol 2005, 94:292-297. Epub 2005 Mar 12.
14. Hodson M.E., Beldon I., Power R., Duncan F.R., Bamber M., Batten J.C. Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) 1983, 286:1381-1383.
15. Hardy J.D., Davison S.H., Higgins M.U., Polycarpou P.N. Sweat tests in the newborn period. Arch Dis Child. 1973, 48:316-318.
16. Parad R.B., Comeau A.M., Dorkin H.L., et al. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005, 147(3 Suppl):S69-72.
17. Eng W., LeGrys V.A., Schechter M.S., Laughon M.M., Barker P.M. Sweat-testing in preterm and full-term infants less than 6 weeks of age. Pediatr Pulmonol 2005, 40:64-67.
18. Eisenhut M., Sidaras D., Barton P., Newland P., Southern K.W. Elevated sweat sodium associated with pulmonary oedema in meningococcal sepsis. Eur J Clin Invest 2004, 34:576-579.
19. Rubin B.K., MacLeod P.M., Sturgess J., King M. Recurrent respiratory infections in a child with fucosidosis: is the mucus too thin for effective transport?. Pediatr Pulmonol 1991, 10:304-309.
20. Lobeck B.B., Barta R.A., Mangos J.A. Study of sweat in pitressin-resistant diabetes insipidus. J Pediatr 1963, 62:868-875.
21. Walpole I.R., Goldblatt J. Rapp-Hodgkin hypohidrotic ectodermal dysplasia syndrome. Clin Genet. 1991, 39:114-120.
22. Main K., Price D.A., Savage M.O., Skakkebaek N.E. Decreased sweating in seven patients with Laron Syndrome. Journal of Clinical Endocrinology and Metabolism; 1993, 77:821-823.
23. Hillemeier A.C., Hen J., Riely C.A., Dolan T.F., Gryboski J.D. Meconium peritonitis and increasing sweat chloride determinations in a case of familial progressive intrahepatic cholestasis. Pediatrics 1982, 69:325-327.
24. Foulston C., Gall G., Mitchell I., Cooper D.M., Scott R.B. Transient neutral fat steatorrhea, elevated sweat chloride concentration, and hypoparathyroidism in a child with celiac disease. J Pediatr Gastroenterol Nutr 1985, 4:143-145.
25. Brand P.L., Gerritsen J., van Aalderen W.M. A baby with eczema and an abnormal sweat test. Lancet 1996, 348:932.
26. Silverman B.L., Lloyd-Still J.D., Hazinski T.A., Hunt C.E. Increased sweat chloride levels associated with prostaglandin E1 infusion. J Pediatr 1985, 106:953-954.
27. Beck R., Goldberg E., Durie P.R., Levison H. Elevated sweat chloride levels in anorexia nervosa. J Pediatr 1986, 108:260-262.
28. Farrell P.M., Koscik R.E. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 1996, 97:524-528.
29. Zielenski J., Tsui L.C. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995, 29:777-807.
30. Wilschanski M., Zielenski J., Markiewicz D., et al. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr 1995, 127:705-710.
31. Lording A., McGaw J., Dalton A., Beal G., Everard M., Taylor C.J. Pulmonary infection in mild variant cystic fibrosis: implications for care. J Cyst Fibros 2006, 5:101-104.
32. Roussey M., Le Bihannic A., Scotet V., et al. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations. J Inherit Metab Dis 2007, 30:613.
33. Lebecque P., Leal T., De Boeck C., Jaspers M., Cuppens H., Cassiman J.J. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children. Am J Respir Crit Care Med 2002, 165:757-761.
34. Desmarquest P., Feldmann D., Tamalat A., et al. Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results. Chest 2000, 118:1591-1597.
35. Padoan R., Bassotti A., Seia M., Corbetta C. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Eur J Pediatr 2002, 161:212-215.
36. Multi-Disciplinary Working Group supported by the Cystic Fibrosis Trust. Evidence-based Guidelines for the Performance of the Sweat Test for the Investigation of Cystic Fibrosis in the UK.
37. LeGrys V.A., Yankaskas J.R., Quittell L.M., Marshall B.C., Mogayzel P.J. Cystic Fibrosis Foundation. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007, 151:85-89.
38. Price C.P., Spencer K. Problems associated with measuring sweat chloride concentration with an ion specific electrode. Ann Clin Biochem 1977, 14:171-178.
39. Emrich H.M., Stoll E., Friolet B., Colombo J.P., Richterich R., Rossi E. Sweat composition in relation to rate of sweating in patients with cystic fibrosis of the pancreas. Pediatr Res 1968, 2:464-478.
40. Hammond K.B., Turcios N.L., Gibson L.E. Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 1994, 124:255-260.
41. Mastella G., Di Cesare G., Borruso A., Menin L., Zanolla L. Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique. Acta Paediatr 2000, 89:933-937.
42. Barben J., Casaulta C., Spinas R., Schoeni M.H. Sweat testing practice in Swiss hospitals. Swiss Med Wkly 2007, 137:192-198.
43. Katherisan N., Gupta A., Mumfoed S., Cade A., Jones R. Sweat conductivity for the diagnosis of cystic fibrosis. J Cystic Fibrosis 2004, 3:205.
44. National Committee for Clinical Laboratory Standards (NCCLS). Sweat Testing: Sample Collection and Quantitative Analysis. Approved guideline C34-A2. Wayne, Pa: NCCLS; 2000.
45. Webster H.L., Quirante C.G. Micro-flowcell conductometric sweat analysis for cystic fibrosis diagnosis. Ann Clin Biochem 2000, 37(Pt 3):399-407.
46. Desax M.C., Ammann R.A., Hammer J., Schoeni M.H., Barben J. Nanoduct(R) sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Eur J Pediatr 2008, 167:299-304. On behalf of the Swiss Paediatric Respiratory Research Group.
47. Barben J., Ammann R.A., Metlagel A., Schoeni M.H. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 2005, 146:183-188. Swiss Paediatric Respiratory Research Group.
48. Mishra A., Greaves R., Massie J. The Limitations of Sweat Electrolyte Reference Intervals for the Diagnosis of Cystic Fibrosis: A Systematic Review. Clin Biochem Rev 2007, 28:60-76.
49. Kirk J.M., Keston M., McIntosh I., Al Essa S. Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases. Ann Clin Biochem 1992, 29(Pt 2):145-152.
50. Gilljam M., Ellis L., Corey M., Zielenski J., Durie P., Tullis D.E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004, 126:1215-1224.
51. Wilschanski M., Famini H., Strauss-Liviatan N., et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001, 17:1208-1215.
52. Knowles M.R., Carson J.L., Collier A.M., Gatzy J.T., Boucher R.C. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 1981, 124:484-490.
53. Boyle M.P., Diener-West M., Milgram L., Knowles M., Foy C., Zeitlin P., et al. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest 2003, 124:482-489.
54. Knowles M.R., Clarke L.L., Boucher R.C. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991, 25:533-538.
55. Mall M., Wissner A., Gonska T., et al. Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cystic fibrosis airways. Am J Respir Cell Mol Biol 2000, 23:755-761.
56. Höfmann T., Bohmer O., Hüls G., et al. Conventional and modified nasal potential-difference measurement in cystic fibrosis. Am J Respir Crit Care Med 1997, 155:1908-1913.
57. Wilson D.C., Ellis L., Zielenski J., Corey M., Ip W.F., Tsui L.C., et al. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr 1998, 132:596-599.
58. Southern K.W., Noone P.G., Bosworth D.G., Legrys V.A., Knowles M.R., Barker P.M. A modified technique for measurement of nasal transepithelial potential difference in infants. The Journal of Pediatrics. 2001, 139:353-358.
59. Munck A, Gerardin M, Godard A, Le Bourgeois M, Gaultier C, Navarro J et al. Nasal transepithelial potential difference in healthy young children. Ped Pulmonol 1999;suppl 19;215 (abstract 180).
60. Schuler D., Sermet-Gaudelus I., Wilschanski M., Ballmann M., Dechaux M., Edelman A., et al. Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros 2004, (Suppl 2):151-155.
61. Standaert T.A., Boitano L., Emerson J., Milgram L.J., Konstan M.W., Hunter J., et al. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatric pulmonology 2004, 37:385-392.
62. Hebestreit A., Kersting U., Basler B., Jeschke R., Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. American journal of respiratory and critical care medicine 2001, 164:443-446.
63. Leal T., Lebacq J., Lebecque P., Cumps J., Wallemacq P. Modified method to measure nasal potential difference. Clin Chem Lab Med 2003, 41:61-67.
64. Jaron R., Yaakov Y., Rivlin J., et al. Nasal potential difference in non-classic cystic fibrosis-long term follow up. Pediatr Pulmonol 2008, 43:545-549.
65. Delmarco A., Pradal U., Cabrini G., Bonizzato A., Mastella G. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur Respir J 1997, 10:1145-1149.
66. Lebecque P., Leal T., De Boeck C., Jaspers M., Cuppens H., Cassiman J.J. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children. American journal of respiratory and critical care medicine 2002, 165:757-761.
67. Fajac I., Hubert D., Guillemot D., Honore I., Bienvenu T., Volter F., et al. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax 2004, 59:971-976.
68. Wallace H.L., Barker P.M., Southern K.W. Nasal airway ion transport and lung function in young people with cystic fibrosis. American journal of respiratory and critical care medicine. 2003, 168:594-600.
69. Crawford I., Maloney P.C., Zeitlin P.L., et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci 1991, 88:9262-9266.
70. O'Loughlin E.V., Hunt D.M., Bostrom T.E., et al. X-ray microanalysis of cell elements in normal and cystic fibrosis jejunum: evidence for chloride secretion in villi. Gastroenterology 1996, 110:411-418.
71. Taylor C.J., Baxter P.S., Hardcastle J., Hardcastle P.T. Absence of secretory response in jejunal biopsy samples from children with cystic fibrosis. Lancet 1987, II:107-108.
72. Taylor C.J., Baxter P.S., Hardcastle J., Hardcastle P.T. Failure to induce secretion in jejunal biopsy samples from children with cystic fibrosis. Gut 1988, 29:957-962.
73. Berschneider H.M., Knowles M.R., Azizkhan R.G., Boucher R.C., Tobey N.A., Orlando R.C., Powell D.W. Altered intestinal chloride transport in cystic fibrosis. FASEB J 1988, 2:2625-2629.
74. O'Loughlin E.V., Hunt D.M., Gaskin K.J., et al. Abnormal epithelial transport in cystic fibrosis jejunum. Am J Physiol 1991, 260:G758-G763.
75. Mall M., Bleich M., Kuehr J., Brandis M., Greger R., Kunzelmann K. CFTR-mediated inhibition of epithelial Na conductance is defective in cystic fibrosis. Am J Physiol 1999, 277:G709-G716.
76. Baxter P.S., Goldhill J., Hardcastle J., Hardcastle P.T., Taylor C.J. Enhanced intestinal glucose and alanine transport in cystic fibrosis. Gut 1990, 31:817-820.
77. Taylor C.J., Hughes H., Hardcastle P.T., Hardcastle J. Genotype and secretory response in cystic fibrosis. Lancet 1992, 339:67-68.
78. - channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 2004, 127:1085-1095.